CA-125 is a blood test that measures the level of a protein called cancer antigen 125. It is commonly used as part of the assessment and monitoring of some ovarian cancers, but it is important to understand what the test can and cannot tell you.

A raised CA-125 level does not, by itself, mean that someone has ovarian cancer. CA-125 can increase for several non-cancerous reasons, including menstruation, endometriosis, ovarian cysts and some infections. Conversely, some people with ovarian cancer, particularly early-stage disease, may have a CA-125 result within the usual reference range.

For these reasons, CA-125 is not a stand-alone diagnostic test or a routine screening test for ovarian cancer in people without symptoms. Its usefulness depends on the clinical situation and how the result is interpreted alongside symptoms, medical history and other investigations.

Understanding The CA-125 Test

CA-125 is a tumour marker. Tumour markers are substances that may be found at higher levels in the blood in association with certain cancers, although they can also be elevated in non-cancerous conditions.

CA-125 is most closely associated with certain types of ovarian cancer, particularly epithelial ovarian cancer. Depending on the circumstances, doctors may use the test during an investigation for possible ovarian cancer, to establish a baseline before treatment, to help monitor treatment response, or as part of follow-up after treatment.

The important point is that CA-125 is one piece of clinical information rather than a diagnosis in itself.

What Does CA-125 Really Show?

A CA-125 result provides information about the amount of the marker measured in a blood sample. Doctors interpret that result in context rather than relying on the number alone.

A raised result can occur with ovarian cancer, but it can also occur with a range of other conditions or normal physiological processes. These may include:

• menstruation
• ovulation
• endometriosis
• ovarian cysts
• fibroids
• pelvic or other infections
• some liver or kidney conditions
• pregnancy

At the same time, a CA-125 result that is not elevated does not completely exclude ovarian cancer. Cancer Council Australia notes that around half of women with early-stage ovarian cancer may not have an elevated CA-125 level.

Is CA-125 A Screening Test For Ovarian Cancer?

No. CA-125 is not recommended as a routine screening test for ovarian cancer in women who do not have symptoms.

Australia does not currently have an effective population-based screening program for ovarian cancer. One reason is that CA-125 can produce both false-positive and false-negative results. An abnormal result may lead to further investigations when cancer is not present, while a normal result cannot reliably exclude early ovarian cancer.

This distinction between screening and investigation is important. Screening involves testing people who do not have symptoms, whereas investigation involves assessing someone because of symptoms, clinical findings or other risk factors.

When Might A Doctor Order A CA-125 Test?

A doctor may consider CA-125 when ovarian cancer is being investigated or when there is another clinical reason to assess the marker.

Possible symptoms of ovarian cancer can include:

• persistent or unusual abdominal bloating
• pelvic or abdominal pain
• feeling full quickly when eating
• changes in urinary habits, such as increased urgency or frequency
• changes in bowel habits
• unexplained fatigue
• unexplained weight changes
• pain during sexual intercourse
• unusual vaginal bleeding.

These symptoms are common and can have many causes other than ovarian cancer. However, if symptoms are new, persistent or concerning, they should be discussed with a doctor rather than relying on a CA-125 test alone.

CA-125 And Ovarian Cancer Diagnosis

If ovarian cancer is suspected, CA-125 may form part of a broader assessment. Depending on the circumstances, this may include a medical history, physical examination, pelvic examination, blood tests and imaging such as a pelvic or transvaginal ultrasound.

CA-125 alone cannot confirm ovarian cancer. If investigations identify a suspicious mass or other abnormality, additional assessment may be required. A biopsy is generally needed to confirm a cancer diagnosis and determine the type of cancer.

CA-125 may be more informative in some circumstances, including after menopause, but the result still needs to be interpreted alongside the rest of the clinical picture.

What Does A CA-125 Level Of 35 U/mL Mean?

A commonly used reference point for CA-125 is around 35 U/mL. However, laboratory reference ranges can vary, and the number should not be interpreted as a simple cancer/no-cancer threshold.

A result above the laboratory’s reference range may require further assessment, but it does not automatically mean ovarian cancer. Menstruation, endometriosis, ovarian cysts and other conditions can also raise CA-125.

Similarly, a result below the reference range does not guarantee that ovarian cancer is absent.

This is why doctors may consider:

• the person’s age and menopausal status
• symptoms and how long they have been present
• personal and family medical history
• known genetic risk factors
• physical examination findings
• ultrasound or other imaging results
• changes in CA-125 over time, where serial testing is clinically appropriate.

CA-125 During Ovarian Cancer Treatment

CA-125 has an established role in monitoring some ovarian cancers that produce the marker.

A baseline result may be obtained before treatment. Further measurements can then be compared over time. A falling CA-125 level may be consistent with a response to treatment, while a rising level may indicate that further assessment is needed.

However, changes in CA-125 should not be interpreted in isolation. Doctors may also consider symptoms, physical findings and imaging results when assessing how cancer is responding to treatment.

A change in CA-125 does not automatically prove that a treatment has succeeded or failed. The clinical context remains important.

CA-125 After Treatment

CA-125 may also be used in some follow-up situations after treatment for ovarian cancer.

When serial testing is appropriate, doctors can compare results over time rather than focusing on one isolated measurement. A rising level may prompt further assessment, but it does not by itself establish that cancer has returned.

Follow-up care is individualised and may involve clinical assessment, imaging and other investigations depending on the type of cancer, treatment history and the person’s circumstances.

Why Can CA-125 Be High Without Cancer?

CA-125 is not specific to ovarian cancer. The level can rise when tissues within the pelvis or abdominal cavity are affected by conditions other than cancer.

For example, CA-125 may be elevated during menstruation or with conditions such as endometriosis, ovarian cysts, fibroids or certain infections. Other medical conditions can also affect the result.

This is one reason an elevated CA-125 result should not be interpreted as a cancer diagnosis.

Why Can CA-125 Be Normal With Ovarian Cancer?

CA-125 is not elevated in every person with ovarian cancer. This is particularly relevant in early-stage disease, where the marker may remain within the usual reference range.

A normal result can therefore be reassuring in some clinical circumstances, but it should not be treated as proof that ovarian cancer has been excluded.

If symptoms or other findings remain concerning, further medical assessment may still be appropriate regardless of the CA-125 result.

CA-125 And Genetic Risk

Some inherited genetic changes, including pathogenic variants in genes such as BRCA1 and BRCA2, can increase the risk of ovarian and other cancers.

A strong family history of ovarian, breast or certain other cancers may also warrant a discussion about inherited cancer risk.

However, having a genetic or family risk does not mean that CA-125 alone is an effective screening strategy. People with increased inherited risk should discuss their individual risk and appropriate surveillance or risk-management options with their GP, specialist or genetics service.

What Happens During A CA-125 Blood Test?

The test itself is straightforward. A healthcare professional collects a small blood sample, usually from a vein in the arm, and sends it to a laboratory for analysis.

For CA-125 alone, fasting is generally not required. However, preparation requirements can depend on whether other blood tests are being performed at the same appointment, so it is sensible to follow the instructions provided by the healthcare service or laboratory.

As with any blood test, there can be brief discomfort at the needle site and occasionally minor bruising or bleeding afterwards.

How Long Does It Take To Get The Result?

The time required to receive a CA-125 result varies between laboratories and healthcare services. Your doctor or pathology provider can explain when the result is expected and how it will be communicated.

More importantly, the result should be interpreted in the context of why the test was ordered. A numerical result without the surrounding clinical information can easily be misunderstood.

What Are The Limitations Of CA-125 Testing?

Understanding the limitations of CA-125 is just as important as understanding its potential uses.

• It is not a routine ovarian cancer screening test. There is currently no effective population screening test for ovarian cancer in Australia.
• It is not specific to cancer. Several non-cancerous conditions can raise CA-125.
• A normal result does not exclude ovarian cancer. Some ovarian cancers do not produce elevated CA-125.
• A high result does not diagnose cancer. Further assessment may be required.
• It should not replace appropriate imaging or clinical assessment.
• Results need to be interpreted individually. Age, menopausal status, symptoms, medical history and other test results can all affect interpretation.

Because an abnormal result can lead to additional investigations, testing without an appropriate clinical reason can create unnecessary uncertainty and follow-up procedures.

CA-125 And Broader Preventive Health

Preventive health involves more than collecting as many biomarkers as possible. The value of a medical test depends on whether the information it provides can meaningfully influence assessment or management.

For ovarian cancer, CA-125 has a role in selected clinical situations, particularly when symptoms are being investigated or when an established ovarian cancer is being monitored. It should not be presented as a general-purpose test that can reliably predict or prevent ovarian cancer in people without symptoms.

Other recommended health checks, such as cervical screening, breast screening and bowel cancer screening, should also be considered according to Australian guidelines and individual risk.

When Should You Speak With A Doctor?

You should speak with a GP or other appropriate healthcare professional if you develop new or persistent symptoms that concern you, particularly symptoms such as ongoing bloating, pelvic or abdominal pain, feeling full quickly, urinary changes or unusual vaginal bleeding.

You should also discuss your risk if you have a significant family history of ovarian or breast cancer or have been identified as carrying a genetic variant associated with increased cancer risk.

If you already have ovarian cancer and are having treatment or follow-up care, your oncology team can explain whether CA-125 is useful for monitoring your particular cancer and how your results should be interpreted.

Final Thoughts

The CA-125 test is a useful clinical tool in the right circumstances, but it is not a simple test for detecting ovarian cancer in everyone.

A raised result does not automatically mean cancer, and a normal result does not completely rule it out. Its value comes from interpreting the result alongside symptoms, medical history, risk factors, imaging and other clinical information.

For people being investigated for possible ovarian cancer or already receiving treatment for a CA-125-producing ovarian cancer, the test can provide useful information. For people without symptoms, however, CA-125 should not be treated as a routine screening test.

If you are considering CA-125 testing, the most useful starting point is a discussion with a qualified healthcare professional about why the test may or may not be appropriate for your individual circumstances.